ClinicalTrials.Veeva

Menu

Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion

W

Wolfson Medical Center (WMC)

Status

Completed

Conditions

Induced; Abortion, Nonmedical

Treatments

Device: Laminaria, MedGyn Products, Inc. USA.
Drug: Misoprostol

Study type

Interventional

Funder types

Other

Identifiers

NCT01678703
2trimabort.CTIL

Details and patient eligibility

About

This study compares the effectiveness of cervical preparation before second trimester abortion using laminaria versus vaginal Misoprostol.

The investigators hypothesize that medical preparation of the cervix with vaginal Misoprostol is superior to mechanical preparation using laminaria.

The investigators believe that medical preparation makes the procedure easier to perform, equally safe, without addition of pain or discomfort.

Full description

This is a prospective randomized study.

The aim of the study is to compare preparation of the cervix before surgical abortion with laminaria and misoprostol.

Primary outcome measures will include:

Initial cervical opening and the need for further dilatation at the procedure Procedure duration

Difficulty score performing the abortion

Complications during and after the procedure

Assessment of pain, using VAS scale, and the need for analgesia before and after the procedure

Enrollment

84 patients

Sex

Female

Ages

15 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant patients with a viable singleton
  • Pregnancy 14-20 weeks of gestation
  • Admitted for termination of pregnancy

Exclusion criteria

  • Contraindication for administration of Misoprostol
  • Patients with more than one previous cesarean section scar
  • Patients with impaired coagulation
  • Significant pulmonary or cardiac disease
  • Non viable pregnancy
  • Placenta accreta or previa by ultrasound

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

84 participants in 2 patient groups

Laminaria group
Active Comparator group
Description:
Patients in this group will have cervical preparation with laminaria MedGyn Products, Inc. USA overnight the day before the abortion
Treatment:
Device: Laminaria, MedGyn Products, Inc. USA.
Misoprostol group
Active Comparator group
Description:
Patients in this group will have cervical preparation with vaginal Misoprostol 600 mcg overnight the day before the abortion
Treatment:
Drug: Misoprostol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems